Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection

Table 1 Comparison between patient age gender and endo-scopic diagnostic results of each group

Group	n	Male/Female	Age (years)	DU/CG
OAC	33	20/13	43.5 (18-70)	18/15
OFC	33	19/14	40.8 (20-70)	17/16
OMC	33	21/12	41.6 (19-69)	18/15
OFA	33	20/13	41.2 (20-70)	19/14
Total	132	80/52	42.0 (18-70)	72/64

Table 2 H pylori eradication rate in each group

Group	Per protocol			Intent to treat
	n	Eradication	Confidence	n	Eradication	Confidence
		rate (%)	interval (95%)		rate (%)	interval (95%)
OAC	31	90.3	79.8-95.6	33	84.9	80.1-92.3
OFC	33	90.9	78.5-97.3	33	90.9	79.6-95.4
OMC	31	70.9	64.0-81.7	33	66.7	62.5-76.7
OFA	32	65.6	59.9-72.2	33	63.6	60.2-71.6
Total	127	79.5	72.4-82.5	33	76.5	70.5-81.8

Table 3 H pylori eradication rate in each group in relation to endoscopic diagnosis

Group	Duodenal ulcer		Chronic gastritis
	n	Eradication rate (%)	n	Eradication rate (%)
OAC	17	88.2	14	92.9
OFC	17	94.1	16	87.5
OMC	16	68.8	15	73.3
OFA	19	57.9	13	76.9
Total	69	76.8	58	82.8

Table 4 Incidence of side effects in each group

Side effects	Incidence of side effects in each group patients (%)
	OAC	OFC	OMC	OFA	Total
	(n = 31)	(n = 33)	(n = 31)	(n = 32)	(n = 127)
Gastroenteric reactions	6.45	9.09	12.9	9.38	9.45
Skin eruption	6.45	0	3.23	6.25	3.94
Headache	6.45	6.06	3.23	0	4.72
Glossitis	0	0	3.23	0	0.79
Weakness	0	0	3.23	0	0.79
Fever	0	3.03	0	0	0.79
Somnolence	3.23	0	3.23	0	1.57